NeuralCure AI has announced a partnership with Life Imaging FLA in the US to expand its decision support system across 200 locations.
This expansion, which will take place over the next five years, will provide physicians with artificial intelligence (AI)-driven insights for clinical decision-making.
Go deeper with GlobalData
The insights will be integrated with the CT scan services of Life Imaging FLA through the expansion.
Life Imaging FLA specialises in preventative imaging to help detect diseases early, and its services are essential in enabling physicians to intervene early and enhance patient outcomes.
NeuralCure AI’s platform is designed to create patient-specific digital twins and run continuous treatment simulations, which support physicians in making precise, data-informed decisions.
Life Imaging FLA CEO Tom Graham said: “Our mission is to provide physicians with the highest-quality imaging services to support better patient care.
“By integrating NeuralCure AI’s advanced decision support technology, we are taking this mission even further, giving doctors the additional insights they need to make life-saving decisions with greater confidence and accuracy.”
Being developed with the expertise of the International Brain Research Foundation and the Institute for Brain Enhancement, NeuralCure AI’s system uses advanced imaging analysis, data models based on research, and predictive analytics.
This aids healthcare professionals in detecting abnormalities sooner and helps to optimise treatment strategies.
With this nationwide expansion, Life Imaging FLA is advancing medical imaging by integrating AI-driven insights into the process of detecting and addressing diseases earlier.
NeuralCure AI CEO Orin Wilson said: “In the coming years, we expect this technology to advance beyond diagnostics, enabling us to reprogramme the human body at the cellular level, activating its own ability to heal, regenerate, and eliminate disease before it ever takes hold.”
